Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

Alaminos M, Dávalos V, Ropero S, Setién F, Paz MF, Herranz M, Fraga MF, Mora J, Cheung NK, Gerald WL, Esteller M.

Cancer Res. 2005 Apr 1;65(7):2565-71.

2.

EMP3 as a candidate tumor suppressor gene for solid tumors.

Fumoto S, Tanimoto K, Hiyama E, Noguchi T, Nishiyama M, Hiyama K.

Expert Opin Ther Targets. 2009 Jul;13(7):811-22. doi: 10.1517/14728220902988549. Review.

PMID:
19466912
4.

Genetic alterations in glioma and medulloblastoma.

Rasheed BK, Bigner SH.

Cancer Metastasis Rev. 1991 Dec;10(4):289-99. Review.

PMID:
1786630
5.

Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death.

Teitz T, Lahti JM, Kidd VJ.

J Mol Med (Berl). 2001 Aug;79(8):428-36. Review.

PMID:
11511973
6.

Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma.

Bigner SH, Vogelstein B.

Brain Pathol. 1990 Sep;1(1):12-8. Review.

PMID:
1669688
7.

[Gene expression profiling of malignant gliomas by cDNA microarrays].

Takahashi H, Kouno J.

Nihon Rinsho. 2005 Sep;63 Suppl 9:515-9. Review. Japanese. No abstract available.

PMID:
16201574
8.

Molecular biology of pediatric gliomas.

Raffel C.

J Neurooncol. 1996 May-Jun;28(2-3):121-8. Review.

PMID:
8832457
9.

DNA methylation in brain development and gliomagenesis.

Costello JF.

Front Biosci. 2003 Jan 1;8:s175-84. Review.

PMID:
12456310
10.

Dominant and recessive molecular changes in neuroblastomas.

Aguzzi A, Ellmeier W, Weith A.

Brain Pathol. 1992 Jul;2(3):195-208. Review.

PMID:
1343834
11.

Mechanisms underlying epigenetically mediated gene silencing in cancer.

Baylin SB.

Semin Cancer Biol. 2002 Oct;12(5):331-7. Review.

PMID:
12191632
12.

Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.

Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W.

Histol Histopathol. 2000 Jul;15(3):971-81. Review.

PMID:
10963139
13.

Genetic and epigenetic alterations in neuroblastoma.

Tonini GP, Romani M.

Cancer Lett. 2003 Jul 18;197(1-2):69-73. Review.

PMID:
12880962
14.

Oncogenes and glial tumors.

Watkins D, Rouleau GA.

Rev Neurol (Paris). 1992;148(6-7):402-7. Review.

PMID:
1448659
15.

DNA-microarray analysis of brain cancer: molecular classification for therapy.

Mischel PS, Cloughesy TF, Nelson SF.

Nat Rev Neurosci. 2004 Oct;5(10):782-92. Review.

PMID:
15378038
16.

Neuropathology, cell biology, and newer diagnostic methods.

Bruner JM, Langford LA, Fuller GN.

Curr Opin Oncol. 1993 May;5(3):441-9. Review.

PMID:
8494905
17.

Oncogenes and anti-oncogenes in human central nervous system tumors.

Batra SK, Rasheed BK, Bigner SH, Bigner DD.

Lab Invest. 1994 Nov;71(5):621-37. Review. No abstract available.

PMID:
7967518
18.

Genetic modeling of glioma formation in mice.

Begemann M, Fuller GN, Holland EC.

Brain Pathol. 2002 Jan;12(1):117-32. Review.

PMID:
11770894
19.

[Cytogenetics of neuroblastoma and glioma].

Chudinovskaia NV.

Arkh Patol. 1992;54(12):33-7. Review. Russian.

PMID:
1296567
20.

Guanine nucleotide binding proteins in neuroblastoma x glioma hybrid, NG108-15, cells. Regulation of expression and function.

Milligan G, McKenzie FR, McClue SJ, Mitchell FM, Mullaney I.

Int J Biochem. 1990;22(7):701-7. Review. No abstract available.

PMID:
2119317
Items per page

Supplemental Content

Support Center